Merit Medical Systems, Inc. has received regulatory approval from Health Canada for its WRAPSODY Cell-Impermeable Endoprosthesis (CIE), a device designed to enhance functional vascular access for ...

Vascular surgeons at St. Peter’s Hospital have performed the Capital Region’s first procedure of its kind to treat ...

The WRAPSODY CIE received premarket approval (PMA) from the US Food and Drug Administration (FDA) in December 2024. Merit began commercialization of the device in the United States in January 2025.

(RTTNews) - Merit Medical Systems, Inc. (MMSI), a healthcare technology company, Tuesday said that its Wrapsody Cell-Impermeable Endoprosthesis (CIE) received approval from Health Canada.

In a significant medical advancement for the Capital Region, vascular surgeons at St. Peter's Hospital have successfully ...

(NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosthesis (CIE) received regulatory approval from Health Canada. With this ...

The Gore TAG Endoprosthesis is composed of a symmetric expanded polytetrafluoroethylene (ePTFE) tube externally reinforced with a layer of ePTFE and fluorinated ethylene propylene (FEP ...

Merit Medical Systems, Inc. MMSI recently announced the FDA's premarket approval for the WRAPSODY Cell-Impermeable Endoprosthesis. With this approval, MMSI can begin commercializing the device in ...

Cookeville Regional Medical Center has added another first to its history books by successfully performing the region's first ...

Merit Medical Systems MMSI released 12-month efficacy results for its WRAPSODY Cell-Impermeable Endoprosthesis (“CIE”), demonstrating strong performance in vascular access maintenance.